Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZY7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,531
Award facts
- Contract value 100% obligated
- $54,531.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $54,531.46 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 15, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for delivering medications and medical supplies across multiple therapeutic domains to military treatment facilities and other federal healthcare programs.
AmerisourceBergen's ability to fulfill this delivery order reflects its established capacity to meet federal procurement requirements through open competition, as evidenced by its extensive portfolio of pharmaceutical product deliveries across diverse therapeutic areas including specialty medications, vaccines, and medical supplies. The firm fixed-price structure and rapid fulfillment timeline demonstrate the efficiency of the delivery order mechanism under the broader IDC vehicle, enabling the Defense Logistics Agency to procure critical pharmaceutical commodities needed to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F0ZY7?
SPE2DR26F0ZY7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F0ZY7 worth?
The government has obligated $54,531 on SPE2DR26F0ZY7.
Is contract SPE2DR26F0ZY7 an order under another contract?
Yes. SPE2DR26F0ZY7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZY7 competed?
The extent of competition for SPE2DR26F0ZY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award